<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> is associated with expression of both inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (iNOS) and cyclooxygenase-2 (COX-2), enzymes whose reaction products contribute to the evolution of ischemic brain injury </plain></SENT>
<SENT sid="1" pm="."><plain>We tested the hypothesis that, after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) produced by iNOS enhances COX-2 activity, thereby increasing the toxic potential of this enzyme </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo> was produced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in rats or mice </plain></SENT>
<SENT sid="3" pm="."><plain>Twenty-four hours after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in rats, iNOS-immunoreactive neutrophils were observed in close proximity (&lt;20 micrometer) to COX-2-positive cells at the periphery of the <z:mpath ids='MPATH_124'>infarct</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>In the olfactory bulb, only COX-2 positive cells were observed </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo> increased the concentration of the COX-2 reaction product <z:chebi fb="0" ids="15551">prostaglandin E2</z:chebi> (<z:chebi fb="0" ids="15551">PGE2</z:chebi>) in the ischemic area and in the ipsilateral olfactory bulb </plain></SENT>
<SENT sid="6" pm="."><plain>The iNOS inhibitor <z:chebi fb="0" ids="40618">aminoguanidine</z:chebi> reduced <z:chebi fb="0" ids="15551">PGE2</z:chebi> concentration in the <z:mpath ids='MPATH_124'>infarct</z:mpath>, where both iNOS and COX-2 were expressed, but not in the olfactory bulb, where only COX-2 was expressed </plain></SENT>
<SENT sid="7" pm="."><plain>Postischemic <z:chebi fb="0" ids="15551">PGE2</z:chebi> accumulation was reduced significantly in iNOS null mice compared with <z:mp ids='MP_0002169'>wild-type</z:mp> controls (C57BL/6 or SV129) </plain></SENT>
<SENT sid="8" pm="."><plain>The data provide evidence that NO produced by iNOS influences COX-2 activity after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Pro-inflammatory <z:chebi fb="0" ids="26347">prostanoids</z:chebi> and reactive oxygen species produced by COX-2 may be a previously unrecognized factor by which NO contributes to ischemic brain injury </plain></SENT>
<SENT sid="10" pm="."><plain>The pathogenic effect of the interaction between NO, or a derived specie, and COX-2 is likely to play a role also in other <z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">brain diseases</z:e> associated with <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
</text></document>